Medtronic's MiniMed 670G - the closest thing ... loop' system comprises a blood glucose sensor, the MiniMed 670G insulin pump and an infusion patch. Type 1 diabetes patients using the device ...

Roche is teaming up with two medical tech companies to develop an automated insulin delivery system, the first steps towards an ‘artificial pancreas.’ The Swiss pharma will work with existing ...

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

Medtronic upgraded to 'Strong Buy' with $104 fair value. Diabetes spin-off boosts focus on core markets, driving growth, ...

The FDA Safer Technologies Program (STeP), a collaborative program, helps reduce the time needed to develop and earn ...

Medtronic (NYSE: MDT) announced some personnel moves, including the departure of a longtime leader across multiple business ...

Medtronic PLC announced Wednesday plans to separate its diabetes business into a new public company, just as the medical-device company reported quarterly results showing that the business was its ...

to enhance focus on high-margin growth drivers for Medtronic and accelerate innovation for the new entity. The diabetes unit, which manufactures insulin pumps and other wearable devices ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced its intent to separate its Diabetes business into a new standalone company ("New Diabetes Company"). This strategic ...

The board of Medtronic plc (NYSE:MDT) has announced that it will be increasing its dividend by 1.4% on the 11th of July to $0.71, up from last year's comparable payment of $0.70. This will take ...